Synerkine Pharma is a Dutch biopharmaceutical company developing novel class of biologics, called Synerkines, that connect different cytokines and enhance their activity via a unique mode of action. By connecting the optimal cytokines, Synerkine is aiming to create a platform of disease modifying Synerkine therapeutics. Synerkine Pharma was founded in 2018 as a spin-off company from the University Medical Center Utrecht.